Boxer Capital Management, LLC
SEC insider (Form 3/4/5 filer). CIK 0002018299. Insider at Tango Therapeutics, Inc. (TNGX) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Nov 6, 2024. Located in SAN DIEGO, CA.
Companies Boxer Capital Management, LLC has filed insider reports for
- Tango Therapeutics, Inc. (TNGX)
- Tyra Biosciences, Inc. (TYRA)
Boxer Capital Management, LLC
CIK: 0002018299
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Nov 6, 2024TNGX
Tango Therapeutics, Inc.
SaleIndirect3.1M shares at avg. $3.14$9.7M - Oct 25, 2024TNGX
Tango Therapeutics, Inc.
SaleDirect633K shares at avg. $6.87$4.3M - Oct 22, 2024TNGX
Tango Therapeutics, Inc.
SaleDirect250K shares at avg. $6.78$1.7M - Oct 21, 2024TNGX
Tango Therapeutics, Inc.
SaleDirect625K shares at avg. $7.05$4.4M - Oct 18, 2024TYRA
Tyra Biosciences, Inc.
DispositionIndirect2M shares- - Oct 18, 2024TYRA
Tyra Biosciences, Inc.
AwardIndirectPre-Funded Warrant (right to purchase)
2M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Nov 6, 2024 |  TNGX Tango Therapeutics, Inc. | Sale | 3,080,000 | $3.14 | $9,671,200 | Indirect |
| Oct 25, 2024 | TNGX Tango Therapeutics, Inc. | Sale | 633,000 | $6.87 | $4,348,710 | Direct |
| Oct 22, 2024 | TNGX Tango Therapeutics, Inc. | Sale | 250,000 | $6.78 | $1,695,000 | Direct |
| Oct 21, 2024 | TNGX Tango Therapeutics, Inc. | Sale | 625,000 | $7.05 | $4,406,250 | Direct |
| Oct 18, 2024 |  TYRA Tyra Biosciences, Inc. | Disposition | 2,000,000 | - | $0 | Indirect |
| Oct 18, 2024 | TYRA Tyra Biosciences, Inc. | Award Pre-Funded Warrant (right to purchase) | 2,000,000 | - | - | Indirect |
1-6 of 6 transactions